These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10184936)

  • 1. Issues and controversies in pharmacoeconomics.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S216-20. PubMed ID: 10184936
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoeconomics perspectives: payers, providers, and patients.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S221-4. PubMed ID: 10184937
    [No Abstract]   [Full Text] [Related]  

  • 3. Methods and mindsets in pharmacoeconomics.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S213-5. PubMed ID: 10184935
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and economic considerations of coronary heart disease: a managed care approach. Proceedings based on presentations from two conferences, Cardiovascular Event Reduction: Defining the Role of HMG Therapy in Managed Care, held November 14-16, 1997 in Philadelphia, and Pharmacoeconomics & Outcomes Issues of Lipid Therapy, held November 5-7, 1997 in Orlando.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S168-233. PubMed ID: 10180343
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary prevention.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S185-90. PubMed ID: 10184933
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacoeconomics and managed care: methodologic and policy issues.
    Luce BR
    Med Decis Making; 1998; 18(2 Suppl):S4-11. PubMed ID: 9566461
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of randomized controlled trials in organizational decision making: a cost-minimization approach.
    Cher DJ; Maclure M
    Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S201-8. PubMed ID: 10184934
    [No Abstract]   [Full Text] [Related]  

  • 9. Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s).
    Valuck R
    Am J Manag Care; 2004 Apr; 10(4):285; author reply 286. PubMed ID: 15124506
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary heart disease in the United States.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S172-7. PubMed ID: 10184932
    [No Abstract]   [Full Text] [Related]  

  • 11. Utilization of generics: a managed care failure?
    Epstein D
    Manag Care; 1997 May; 6(5):85-7. PubMed ID: 10168639
    [No Abstract]   [Full Text] [Related]  

  • 12. Study confirms impact of improper asthma drug therapy.
    Healthc Demand Dis Manag; 1998 Feb; 4(2):26-8. PubMed ID: 10178016
    [No Abstract]   [Full Text] [Related]  

  • 13. Managed care as a public cost-containment mechanism.
    Goldman DP
    Rand J Econ; 1995; 26(2):227-95. PubMed ID: 10160534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stats & facts. More consumer cost sharing in pharmacy benefit.
    Manag Care Interface; 2002 Apr; 15(4):34-5. PubMed ID: 11979701
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial.
    Lindgren P; Jönsson B; Yusuf S
    J Intern Med; 2004 May; 255(5):562-70. PubMed ID: 15078498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medicalization of the coronary patient].
    Jacobsen CD
    Tidsskr Nor Laegeforen; 1994 Oct; 114(26):3119. PubMed ID: 7974440
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacoeconomics in cardiovascular disease. Part 1: pharmacoeconomics in coronary heart disease].
    Wozakowska-Kapłon B; Kempkiewicz T
    Pol Arch Med Wewn; 2003 Nov; 110(5):1367-73. PubMed ID: 16737009
    [No Abstract]   [Full Text] [Related]  

  • 18. Are drugs a cost or an investment?
    Goetzel RZ; Ozminkowski RJ; Del Rosso G; Schutt DC
    Bus Health; 2000 Jun; 18(6):39-42, 45. PubMed ID: 11067243
    [No Abstract]   [Full Text] [Related]  

  • 19. The appointment-keeping habits of managed care patients.
    Lilja J
    Physician Exec; 1994 Aug; 20(8):35-8. PubMed ID: 10139373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced mortality rates after intensive statin therapy in managed-care patients.
    Fintel D; Joyce A; Mackell J; Graff J; Kuntze E; Ollendorf DA
    Value Health; 2007; 10(2):161-9. PubMed ID: 17391425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.